| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092064500 |
| P356 | DOI | 10.1186/S12864-017-4027-5 |
| P932 | PMC publication ID | 5629558 |
| P698 | PubMed publication ID | 28984201 |
| P2093 | author name string | Vladimir A Kuznetsov | |
| Zhiqun Tang | |||
| Anna V Ivshina | |||
| P2860 | cites work | miRBase: integrating microRNA annotation and deep-sequencing data | Q24615914 |
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application | Q24803815 | ||
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer | Q26780387 | ||
| Regulatory networks between neurotrophins and miRNAs in brain diseases and cancers | Q26864655 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| MicroRNA signatures in human ovarian cancer | Q28249211 | ||
| Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance | Q28307294 | ||
| Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma | Q28730850 | ||
| MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 | ||
| Adjusting batch effects in microarray expression data using empirical Bayes methods | Q29614937 | ||
| MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN | Q29616575 | ||
| A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis | Q30540674 | ||
| MicroRNA expression and identification of putative miRNA targets in ovarian cancer | Q33344505 | ||
| Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome | Q33359495 | ||
| Data-driven approach to predict survival of cancer patients: estimation of microarray genes' prediction significance by Cox proportional hazard regression model | Q33485041 | ||
| Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression | Q33531529 | ||
| Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. | Q33559304 | ||
| The biology of ovarian cancer: new opportunities for translation | Q33622369 | ||
| MicroRNAs in ovarian carcinomas | Q33796565 | ||
| Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers | Q33886925 | ||
| TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. | Q33927452 | ||
| A microRNA survival signature (MiSS) for advanced ovarian cancer. | Q34167137 | ||
| Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas | Q34295802 | ||
| Computing Inter-Rater Reliability for Observational Data: An Overview and Tutorial. | Q34352215 | ||
| Potential markers that complement expression of CA125 in epithelial ovarian cancer | Q34439240 | ||
| Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence | Q34648126 | ||
| Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells | Q34816792 | ||
| Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer | Q35044404 | ||
| Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development | Q35590845 | ||
| The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. | Q35808837 | ||
| DIANA-miRPath v3.0: deciphering microRNA function with experimental support | Q35810103 | ||
| Rethinking ovarian cancer: recommendations for improving outcomes | Q36050883 | ||
| Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples. | Q36087199 | ||
| MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features | Q36253778 | ||
| Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors | Q36294516 | ||
| Role of neurotrophic factors in early ovarian development | Q36475959 | ||
| The UCSC Genome Browser database: extensions and updates 2013. | Q36491237 | ||
| Prognostically relevant gene signatures of high-grade serous ovarian carcinoma | Q36497294 | ||
| Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer | Q36657641 | ||
| Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer | Q37040827 | ||
| Survival-related profile, pathways, and transcription factors in ovarian cancer | Q37081275 | ||
| New insights into the pathogenesis of serous ovarian cancer and its clinical impact | Q37119411 | ||
| Ovarian carcinoma pathology and genetics: recent advances | Q37529986 | ||
| Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification | Q37711615 | ||
| Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer | Q37725034 | ||
| MiRNAs as biomarkers and therapeutic targets in cancer | Q37764475 | ||
| Serum microRNAs as powerful cancer biomarkers | Q37773488 | ||
| MicroRNA regulation of epithelial plasticity in cancer | Q38066319 | ||
| Neurotrophin signaling in cancer stem cells | Q38736387 | ||
| Exosome-derived miRNAs and ovarian carcinoma progression | Q38985333 | ||
| Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach. | Q39042186 | ||
| An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. | Q40172885 | ||
| Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma. | Q50859800 | ||
| MicroRNA expression profiles in serous ovarian carcinoma. | Q53321694 | ||
| Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer | Q57202934 | ||
| Origin of ovarian cancer may have implications for screening | Q82295888 | ||
| MicroRNAs as biomarkers and therapeutic drugs in human cancer | Q83034659 | ||
| P433 | issue | Suppl 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 692 | |
| P577 | publication date | 2017-10-03 | |
| P1433 | published in | BMC Genomics | Q15765854 |
| P1476 | title | Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets | |
| P478 | volume | 18 |
| Q99710790 | PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers |
| Q90652860 | Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction |
| Q42371174 | The International Conference on Intelligent Biology and Medicine (ICIBM) 2016: summary and innovation in genomics |
Search more.